肌无力-话题@MedSci - 梅斯（MedSci）

#肌无力#

50篇内容 | 2280人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2179057, encodeId=78f921e905776, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=【今日解读分享】2023 DGN指南：肌无力综合征的管理, objectType=article, longId=808061, objectId=c47380806179, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230321/1679466969195_4754896.jpeg, objectUrl=/article/show_article.do?id=c47380806179, replyNumber=0, likeNumber=65, createdTime=2024-01-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c47380806179, moduleTitle=【今日解读分享】2023 DGN指南：肌无力综合征的管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c47380806179)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1436688, encodeId=432f143668824, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=先天性肌无力综合征：症状与体征、病因、流行病学、诊断与治疗, objectType=article, longId=739358, objectId=7016e3935899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7016e3935899, replyNumber=0, likeNumber=103, createdTime=2022-09-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7016e3935899, moduleTitle=先天性肌无力综合征：症状与体征、病因、流行病学、诊断与治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7016e3935899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436687, encodeId=d938143668eca, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=JNNP：细胞检测在血清阴性重症肌无力表征中的临床价值, objectType=article, longId=735204, objectId=6359e352045d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6359e352045d, replyNumber=0, likeNumber=95, createdTime=2022-08-09, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6359e352045d, moduleTitle=JNNP：细胞检测在血清阴性重症肌无力表征中的临床价值, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6359e352045d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436686, encodeId=bf101436686e6, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=NEJM Evid：Ravulizumab用于抗AchR抗体阳性重症肌无力效果持久有效（CHAMPION MG研究）, objectType=article, longId=726131, objectId=557fe26131ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=557fe26131ca, replyNumber=0, likeNumber=89, createdTime=2022-05-06, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=557fe26131ca, moduleTitle=NEJM Evid：Ravulizumab用于抗AchR抗体阳性重症肌无力效果持久有效（CHAMPION MG研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=557fe26131ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436685, encodeId=97e31436685d5, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=JNNP:厄瓜利珠单抗与利妥昔单抗治疗全身性重症肌无力的比较, objectType=article, longId=300333, objectId=438830033364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=438830033364, replyNumber=0, likeNumber=89, createdTime=2022-03-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=438830033364, moduleTitle=JNNP:厄瓜利珠单抗与利妥昔单抗治疗全身性重症肌无力的比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=438830033364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436684, encodeId=73c81436684e0, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=FDA 批准Vyvgart 治疗全身性重症肌无力, objectType=article, longId=292400, objectId=0146292400bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0146292400bd, replyNumber=0, likeNumber=76, createdTime=2021-12-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0146292400bd, moduleTitle=FDA 批准Vyvgart 治疗全身性重症肌无力, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0146292400bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436683, encodeId=2c28143668320, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=Neurology：利妥昔单抗治疗乙酰胆碱受体抗体阳性重症肌无力的2期试验：安全、耐受性良好，但不可显著减少类固醇使用, objectType=article, longId=221575, objectId=e6ec2215e50a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6ec2215e50a, replyNumber=0, likeNumber=84, createdTime=2021-12-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6ec2215e50a, moduleTitle=Neurology：利妥昔单抗治疗乙酰胆碱受体抗体阳性重症肌无力的2期试验：安全、耐受性良好，但不可显著减少类固醇使用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e6ec2215e50a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436682, encodeId=1a3d143668298, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=半数重症肌无力患者在黄金年龄发病，创新疗法有望带来突破, objectType=article, longId=217782, objectId=d4ce21e78213, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4ce21e78213, replyNumber=0, likeNumber=68, createdTime=2021-09-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4ce21e78213, moduleTitle=半数重症肌无力患者在黄金年龄发病，创新疗法有望带来突破, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d4ce21e78213)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436681, encodeId=8e55143668146, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=Neurology：瑞典千人队列：重症肌无力患者的整体状态如何？, objectType=article, longId=215757, objectId=f9fa215e57d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9fa215e57d6, replyNumber=0, likeNumber=101, createdTime=2021-08-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9fa215e57d6, moduleTitle=Neurology：瑞典千人队列：重症肌无力患者的整体状态如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f9fa215e57d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436680, encodeId=6b4d14366807f, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=早发、晚发型症肌无力患者治疗新靶向：基因、免疫通路大不相同, objectType=article, longId=215120, objectId=007921512065, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=007921512065, replyNumber=0, likeNumber=95, createdTime=2021-08-02, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=007921512065, moduleTitle=早发、晚发型症肌无力患者治疗新靶向：基因、免疫通路大不相同, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=007921512065)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436679, encodeId=d40614366e9c0, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=Ann Neurol-早发vs晚发的重症肌无力，在基因组学上有何差异？, objectType=article, longId=214822, objectId=23142148222e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23142148222e, replyNumber=0, likeNumber=105, createdTime=2021-07-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23142148222e, moduleTitle=Ann Neurol-早发vs晚发的重症肌无力，在基因组学上有何差异？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=23142148222e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436678, encodeId=231014366e85f, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=重症肌无力一网打尽！众多分型临床表现帮你记？, objectType=article, longId=214627, objectId=99ab21462e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99ab21462e78, replyNumber=0, likeNumber=106, createdTime=2021-07-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99ab21462e78, moduleTitle=重症肌无力一网打尽！众多分型临床表现帮你记？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=99ab21462e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436677, encodeId=1b2514366e77c, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=JNNP：乙酰胆碱受体抗体水平变化率预测重症肌无力预后, objectType=article, longId=209778, objectId=a27e209e78e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a27e209e78e4, replyNumber=0, likeNumber=143, createdTime=2021-04-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a27e209e78e4, moduleTitle=JNNP：乙酰胆碱受体抗体水平变化率预测重症肌无力预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a27e209e78e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436676, encodeId=c86214366e627, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=眼皮耷拉肌无力，竟和胸口这块“石头”有关！什么病，这么厉害？, objectType=article, longId=209524, objectId=5e6820952459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e6820952459, replyNumber=0, likeNumber=83, createdTime=2021-04-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e6820952459, moduleTitle=眼皮耷拉肌无力，竟和胸口这块“石头”有关！什么病，这么厉害？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5e6820952459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436675, encodeId=ad8a14366e583, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=JAMA neurology：重症肌无力患者不同激素治疗方案的效果比较, objectType=article, longId=207109, objectId=94f720e10924, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94f720e10924, replyNumber=0, likeNumber=89, createdTime=2021-02-15, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94f720e10924, moduleTitle=JAMA neurology：重症肌无力患者不同激素治疗方案的效果比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=94f720e10924)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436674, encodeId=59c814366e4c2, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=JAMA Neurol：泼尼松冲击疗法联合快减量方案治疗中重度重症肌无力, objectType=article, longId=207047, objectId=029920e047d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=029920e047d8, replyNumber=0, likeNumber=130, createdTime=2021-02-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=029920e047d8, moduleTitle=JAMA Neurol：泼尼松冲击疗法联合快减量方案治疗中重度重症肌无力, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=029920e047d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436673, encodeId=197714366e39b, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=Nat Commun：全基因组荟萃分析确定与老年人肌无力相关的15个易感基因座, objectType=article, longId=206850, objectId=020320685078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=020320685078, replyNumber=0, likeNumber=85, createdTime=2021-02-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=020320685078, moduleTitle=Nat Commun：全基因组荟萃分析确定与老年人肌无力相关的15个易感基因座, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=020320685078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436672, encodeId=84e314366e242, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=Acta Neuropathologica：血清阴性重症肌无力患者神经肌肉接头补体沉积, objectType=article, longId=199037, objectId=e07119903e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e07119903e5f, replyNumber=0, likeNumber=72, createdTime=2020-08-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e07119903e5f, moduleTitle=Acta Neuropathologica：血清阴性重症肌无力患者神经肌肉接头补体沉积, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e07119903e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436671, encodeId=b0c014366e1aa, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=Sci Rep：肌无力综合征的肺癌预测, objectType=article, longId=196782, objectId=d20c196e824a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d20c196e824a, replyNumber=0, likeNumber=52, createdTime=2020-07-01, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d20c196e824a, moduleTitle=Sci Rep：肌无力综合征的肺癌预测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d20c196e824a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436670, encodeId=26c814366e00b, content=<a href='/topic/show?id=e7c18092578' target=_blank style='color:#2F92EE;'>#肌无力#</a>, objectTitle=抗体片段efgartigimod治疗重症肌无力：III期试验迎硕果！, objectType=article, longId=194860, objectId=254019486069, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=254019486069, replyNumber=0, likeNumber=81, createdTime=2020-05-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=254019486069, moduleTitle=抗体片段efgartigimod治疗重症肌无力：III期试验迎硕果！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=254019486069)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肌无力

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肌无力#

【今日解读分享】2023 DGN指南：肌无力综合征的管理

2024-01-03发表于上海

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

先天性肌无力综合征：症状与体征、病因、流行病学、诊断与治疗

2022-09-16

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

JNNP：细胞检测在血清阴性重症肌无力表征中的临床价值

2022-08-09

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

NEJM Evid：Ravulizumab用于抗AchR抗体阳性重症肌无力效果持久有效（CHAMPION MG研究）

2022-05-06

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

JNNP:厄瓜利珠单抗与利妥昔单抗治疗全身性重症肌无力的比较

2022-03-10

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

FDA 批准Vyvgart 治疗全身性重症肌无力

2021-12-22

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

Neurology：利妥昔单抗治疗乙酰胆碱受体抗体阳性重症肌无力的2期试验：安全、耐受性良好，但不可显著减少类固醇使用

2021-12-07

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

半数重症肌无力患者在黄金年龄发病，创新疗法有望带来突破

2021-09-29

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

Neurology：瑞典千人队列：重症肌无力患者的整体状态如何？

2021-08-16

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

早发、晚发型症肌无力患者治疗新靶向：基因、免疫通路大不相同

2021-08-02

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

Ann Neurol-早发vs晚发的重症肌无力，在基因组学上有何差异？

2021-07-27

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

重症肌无力一网打尽！众多分型临床表现帮你记？

2021-07-24

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

JNNP：乙酰胆碱受体抗体水平变化率预测重症肌无力预后

2021-04-11

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

眼皮耷拉肌无力，竟和胸口这块“石头”有关！什么病，这么厉害？

2021-04-05

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

JAMA neurology：重症肌无力患者不同激素治疗方案的效果比较

2021-02-15

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

JAMA Neurol：泼尼松冲击疗法联合快减量方案治疗中重度重症肌无力

2021-02-12

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

Nat Commun：全基因组荟萃分析确定与老年人肌无力相关的15个易感基因座

2021-02-07

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

Acta Neuropathologica：血清阴性重症肌无力患者神经肌肉接头补体沉积

2020-08-10

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

Sci Rep：肌无力综合征的肺癌预测

2020-07-01

zhouqu_8 (审核中...)

前往app查看评论内容

#肌无力#

抗体片段efgartigimod治疗重症肌无力：III期试验迎硕果！

2020-05-29

科室
- - 订阅+
  - 更多科室
工具
服务